SCHEDULE: Vanguard Group Discloses 11.8% Stake in Chemours Co

The Vanguard Group has filed an amended Schedule 13G, revealing its beneficial ownership of 11.8% of Chemours Co/The's common stock as of June 30, 2025.

Summary

• The Vanguard Group reported beneficial ownership of 17,663,980 shares of Chemours Co/The common stock.
• This ownership represents 11.8% of the total class of securities.
• Vanguard holds sole dispositive power over 17,324,381 shares and shared dispositive power over 339,599 shares.
• Vanguard holds no sole voting power and shared voting power over 181,238 shares.
• This filing is Amendment No. 10, indicating a series of previous beneficial ownership disclosures by Vanguard regarding Chemours Co/The.

Sentiment

Score: 7

Explanation: The filing indicates a substantial and continued beneficial ownership stake by The Vanguard Group, a major institutional investor, in Chemours Co/The. While a Schedule 13G is a passive filing, the presence of a large, stable institutional holder can be viewed positively by the market as it suggests long-term confidence in the company's value.

Positives

• A significant and continued beneficial ownership stake by a major institutional investor like The Vanguard Group can signal confidence in the company's long-term prospects.
• The presence of a large, stable institutional holder on the shareholder register suggests a degree of market validation for Chemours Co/The.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Chemours Co/The's future performance or strategic direction.

Industry Context

Schedule 13G filings are mandatory disclosures by institutional investors who acquire more than 5% beneficial ownership in a company's stock, indicating a passive investment intent. The Vanguard Group, as one of the world's largest investment management companies, frequently appears in such filings across numerous public companies, reflecting its broad index-tracking and actively managed fund portfolios. This filing indicates Vanguard's continued significant, passive stake in Chemours Co/The.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holder like Vanguard can provide a sense of stability and validation for other investors, potentially influencing investor sentiment.
• Company Management: Awareness of a large, passive institutional shareholder may influence corporate governance considerations, though Vanguard typically does not seek to influence control.

Key Dates

Keywords

Chemours Co, Vanguard Group, Schedule 13G, beneficial ownership, institutional investor, common stock, equity, SEC filing